Market News & Trends
MilliporeSigma's CRISPR Epigenetic Activator Named on Top 10 Innovation List
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada, recently announced that The Scientist magazine…
Exclusive: Capsugel Prepares to Explore Sale or IPO
By: Carl O’Donnell & Greg Roumeliotis Capsugel, a U.S. maker of capsule products and other drug delivery systems, is preparing to explore a sale or…
Quantum Genomics Raises Millions in US & Europe
Quantum Genomics recently announced it has completed a private placement with US institutional investors totalling €5.54 million. Directly following the US capital increase, the company…
Placon Therapeutics Announces Company Launch and FDA Acceptance of IND
Placon Therapeutics recently announced its launch as an independent company and provided an update on its lead product candidate, BTP-114, for which the US FDA…
NDA Group & PharmApprove Announce Merger
NDA Group and PharmApprove recently announced their merger. The newly combined company will allow clients to streamline the global development and commercialization process, accelerating patient…
Genisphere Enters Collaborative Nanotherapeutics Research Agreement
Genisphere LLC has signed a collaborative research agreement with the University of Pennsylvania to study targeted nanotherapeutics in cancer treatment. The collaboration between Genisphere LLC,…
Daiichi Sankyo & ArQule Announce Continuation of Phase III Study
ArQule, Inc. and Daiichi Sankyo recently announced that the independent data monitoring committee (DMC) of the METIV-HCC study conducted the planned interim assessment, and it…
Aduro Biotech Announces First Patient Dosed in Combination Clinical Trial
Aduro Biotech, Inc. recently announced that the first patient has been dosed in SEASCAPE, the Phase I/II clinical study designed to evaluate the safety, tolerability…
Ascendia Pharma Announces New Contract Manufacturing Capability to Deliver cGMP Phase I Clinical Trial Materials
Ascendia now offers cGMP manufacturing capabilities for both oral and parenteral dosage forms to support your Phase I clinical trials. We have recently finished the qualification…
Patheon Signs Flexible Manufacturing Agreement With Amgen
Patheon, the leading global provider of pharmaceutical development and manufacturing services, recently announced it has signed a manufacturing agreement with Amgen, one of the world’s…
Inovio Pharmaceuticals Acquires Needle-Free Injection Technology to Advance Strategy for Next-Generation Vaccines
Inovio Pharmaceuticals, Inc. recently announced it has signed a definitive agreement to acquire all of Bioject Medical Technologies Inc.’s assets, including pioneering needle-free jet injection…
CordenPharma Announces Expanded Aseptic & Oral Development Capabilities
As part of a long term strategy to meet increasing customer demands, CordenPharma has completed two additional key investments to strengthen its development and manufacturing…
Chiasma Initiates Second Phase III Trial of Octreotide Capsules
Chiasma, Inc. recently announced the initiation of a second Phase III clinical trial to investigate the non-inferiority of octreotide capsules to once-a-month injectable somatostatin analogs.…
Caladrius Biosciences Subsidiary Enters Into Global Collaboration & License Agreement
Caladrius Biosciences, Inc. recently announced that, through its subsidiary, PCT, has entered into a global collaboration with Hitachi Chemical Co., Ltd. that includes licensing, development,…
Ajinomoto Althea Expands Capacity of Fill Finish Manufacturing
Ajinomoto Althea, Inc. recently announced it is expanding the capacity of its Fill and Finish operations through the addition of a second manufacturing shift. Althea's…
Gastric Cancer Drug Development Shifting From Small Molecules to Monoclonal Antibodies
While 99% of currently marketed gastric cancer drugs are small molecules, this dominance could give way to more innovative treatments in future, as the pipeline…
Formulation Development Success Story: Uric Acid Treatment Approved by FDA
The U.S. Food and Drug Administration recently approved a new uric acid treatment that was developed as a partnership between Metrics Contract Services and the…
Foster Introduces ProFlex for Soft Touch Medical Devices
Foster Corporation recently announced the introduction of ProFlex styrene-ethylene butylene-styrene (SEBS) for medical device applications. These polymers offer a low-cost alternative to other thermoplastic elastomers…
Glioblastoma Treatment Hopes Turn to Combining Peptide Vaccines With Immuno-Oncology Products
The termination of Celldex’s Phase III trial assessing its peptide-based vaccine therapy, Rintega, in newly diagnosed glioblastoma patients, represents a blow to the treatment space…
Immunomedics Develops Novel Antibody-Based Products for Autoimmune Disease & Cancer Therapy
Immunomedics, Inc. recently announced that the issuance of US Patent No. 9,278,129 for the company’s new patent family Methods of Treating Rapidly Progressive Glomerulonephritis Using…
